Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical Study

Extracorporeal circulation (ECC) is frequently used in intensive care patients with impaired lung or cardiac function. Despite being life-saving therapeutic option, ECC is associated with increased risk for both bleeding and thrombosis. The management of bleeding and thromboembolic events in ECC patients is still challenging partly due to the lack of information on the pathophysiological changes in hemostasis and platelet function during the procedure. Using a combination of an ex vivo model for shear stress and a sensitive and easy-to-use laboratory method we analyzed platelet responsiveness during ECC. After shear stress simulation in an ex vivo closed-loop ECC model we found a significantly decreased response of alpha granules after activation with ADP and TRAP-6 and CD63 expression after activation with TRAP-6. Mepacrine uptake was also significantly reduced in the ex vivo shear stress model. In the same line, platelets from patients under ECC with venovenous systems and venoarterial systems showed impaired CD62P degranulation after stimulation with ADP and TRAP-6 compared to healthy control on day 1, 6 and 10 after implantation of ECC. However, no correlation between platelet degranulation and the occurrence of bleeding or thromboembolic events was observed. The used whole Blood flow cytometry with immediately fixation after drawing introduces a sensitive and easy-to-use method to determine platelet activation status and our data confirm that increased shear stress conditions under ECC can cause impaired degranulation of platelet.

[1]  I. Gouin-Thibault,et al.  Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation , 2020, Journal of clinical medicine.

[2]  H. Wendel,et al.  Multi-Modal Characterization of the Coagulopathy Associated With Extracorporeal Membrane Oxygenation , 2020, Critical care medicine.

[3]  Jiafeng Zhang,et al.  The impact of shear stress on device-induced platelet hemostatic dysfunction relevant to thrombosis and bleeding in mechanically assisted circulation. , 2019, Artificial organs.

[4]  F. Moreira,et al.  Extracorporeal membrane oxygenation: a literature review , 2019, Revista Brasileira de terapia intensiva.

[5]  B. Griffith,et al.  High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity , 2019, Platelets.

[6]  F. Beyersdorf,et al.  Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices , 2018, Hämostaseologie.

[7]  B. Hunt,et al.  Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components , 2018, Front. Med..

[8]  H. Schulze,et al.  Functional Classification of Paediatric Patients with Non-syndromic Delta-Storage Pool Deficiency , 2018, Hämostaseologie.

[9]  A. Hvas,et al.  Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients: A Systematic Review , 2018, Front. Cardiovasc. Med..

[10]  L. Prahl Wittberg,et al.  Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit , 2018, Scientific Reports.

[11]  B. Zieger,et al.  Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  J. Teruya,et al.  Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation , 2017, Seminars in Thrombosis and Hemostasis.

[13]  J. Bartek,et al.  Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): An observational cohort study , 2017, PloS one.

[14]  Geetanjali Dang,et al.  Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis , 2017, ASAIO journal (1992).

[15]  L. Kritharides,et al.  Flow Cytometry Protocols for Assessment of Platelet Function in Whole Blood. , 2017, Methods in molecular biology.

[16]  J. Shaw,et al.  Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI , 2016, Journal of thrombosis and haemostasis : JTH.

[17]  J. Moake,et al.  Acquired von Willebrand syndrome associated with left ventricular assist device. , 2016, Blood.

[18]  K. Muthiah,et al.  Longitudinal changes in hemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous-flow left ventricular assist devices. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  U. Strauch,et al.  Venovenous Extracorporeal Membrane Oxygenation in Intractable Pulmonary Insufficiency: Practical Issues and Future Directions , 2016, BioMed research international.

[20]  T. Bein,et al.  Hemostatic Changes During Extracorporeal Membrane Oxygenation: A Prospective Randomized Clinical Trial Comparing Three Different Extracorporeal Membrane Oxygenation Systems , 2015, Critical care medicine.

[21]  I. Alferiev,et al.  The use of the ex vivo Chandler Loop Apparatus to assess the biocompatibility of modified polymeric blood conduits. , 2014, Journal of visualized experiments : JoVE.

[22]  M. Lordkipanidzé,et al.  Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders , 2014, Journal of thrombosis and haemostasis : JTH.

[23]  A. Schmaier,et al.  Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH , 2013, Journal of thrombosis and haemostasis : JTH.

[24]  M. Linden Platelet flow cytometry. , 2013, Methods in molecular biology.

[25]  Klaus Görlinger,et al.  Coagulation management in patients undergoing mechanical circulatory support. , 2012, Best practice & research. Clinical anaesthesiology.

[26]  W. van Oeveren,et al.  Comparison of Modified Chandler, Roller Pump, and Ball Valve Circulation Models for In Vitro Testing in High Blood Flow Conditions: Application in Thrombogenicity Testing of Different Materials for Vascular Applications , 2012, International journal of biomaterials.

[27]  M. Givertz,et al.  Mechanical Circulatory Support for Advanced Heart Failure: Patients and Technology in Evolution , 2012, Circulation.

[28]  H. Wendel,et al.  A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4 , 2011, Journal of materials science. Materials in medicine.

[29]  R. Bartlett,et al.  Hemolysis and ECMO pumps in the 21st Century , 2011, Perfusion.

[30]  C. Schlensak,et al.  Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS) , 2011, Intensive Care Medicine.

[31]  M. Olschewski,et al.  Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. , 2010, Interactive cardiovascular and thoracic surgery.

[32]  Rajko Radovancevic,et al.  Increased Leukocyte-Platelet Interactions During Circulatory Support With Left Ventricular Assist Devices , 2009, ASAIO journal.

[33]  R. Autschbach,et al.  Past, Present, and Future of Long‐Term Mechanical Cardiac Support in Adults , 2008, Journal of cardiac surgery.

[34]  A. Larsson,et al.  Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents , 2006, Platelets.

[35]  P. Roberson,et al.  Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. , 2003, Journal of vascular and interventional radiology : JVIR.

[36]  P. Ridker,et al.  Soluble P-Selectin and the Risk of Future Cardiovascular Events , 2001, Circulation.

[37]  Khan,et al.  Arachidonic acid metabolites alter G protein-mediated signal transduction in heart. Effects on muscarinic K+ channels , 1990, The Journal of general physiology.

[38]  S. Ritz‐Timme,et al.  Genesis and diagnostic value of leukocyte and platelet accumulations around “air bubbles” in blood after venous air embolism , 1997, International Journal of Legal Medicine.

[39]  A. Michelson Flow cytometry: a clinical test of platelet function. , 1996, Blood.

[40]  T. Thorsen,et al.  Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression. , 1993, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[41]  J. Hoxie,et al.  DETECTION OF ACTIVATED PLATELETS IN WHOLE BLOOD BY FLOW CYTOMETRY , 1987, Thrombosis and Haemostasis.

[42]  J. Hoxie,et al.  Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. , 1987, Blood.